Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutation.
Thavaneswaran S, Lin F, Grady JP, Espinoza D, Huang ML, Chinchen S, Sebastian L, Kansara M, Mersiades T, Lee CK, Desai J, Grimison P, Brown M, Millward M, Harrup R, O'Byrne K, Nagrial A, Craft P, Simes J, Joshua AM, Thomas DM. Thavaneswaran S, et al. Among authors: brown m. NPJ Precis Oncol. 2024 Sep 9;8(1):195. doi: 10.1038/s41698-024-00698-4. NPJ Precis Oncol. 2024. PMID: 39251683 Free PMC article.
A phase II trial of larotrectinib in tumors with NTRK fusions or extremes of NTRK mRNA overexpression identified by comprehensive genomic profiling.
Thavaneswaran S, Sim HW, Grady J, Espinoza D, Huang ML, Lin F, McGrath M, Desai J, Charakidis M, Brown M, Kansara M, Simes J, Thomas D. Thavaneswaran S, et al. Among authors: brown m. Oncologist. 2024 Dec 25:oyae339. doi: 10.1093/oncolo/oyae339. Online ahead of print. Oncologist. 2024. PMID: 39720993 Free article.
An expanded phylogenomic analysis of Heterolobosea reveals the deep relationships, non-canonical genetic codes, and cryptic flagellate stages in the group.
Pánek T, Tice AK, Corre P, Hrubá P, Žihala D, Kamikawa R, Yazaki E, Shiratori T, Kume K, Hashimoto T, Ishida KI, Hradilová M, Silberman JD, Roger A, Inagaki Y, Eliáš M, Brown MW, Čepička I. Pánek T, et al. Among authors: brown mw. Mol Phylogenet Evol. 2025 Jan 16:108289. doi: 10.1016/j.ympev.2025.108289. Online ahead of print. Mol Phylogenet Evol. 2025. PMID: 39826589
Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort.
Yang J, Burrello J, Goi J, Reincke M, Adolf C, Asbach E, Brűdgam D, Li Q, Song Y, Hu J, Yang S, Satoh F, Ono Y, Libianto R, Stowasser M, Li N, Zhu Q, Hong N, Nayak D, Puar TH, Wu VC, Vaidya A, Araujo-Castro M, Kocjan T, O'Toole SM, Hundemer GL, Ragnarsson O, Lacroix A, Larose S, Nakai K, Nishikawa T, Ladygina D, Turcu AF, Sholinyan J, Fardella CE, Uslar T, Quinkler M, Mulatero P, Pintus G, Rossi GP, Hahner S, Amar L, Drake WM, Varsani C, Brown MJ, Wu X, Deinum J, Freel EM, Kline G, Naruse M, Prejbisz A, Young WF Jr, Williams TA, Fuller PJ. Yang J, et al. Among authors: brown mj. Lancet Diabetes Endocrinol. 2025 Jan 14:S2213-8587(24)00308-5. doi: 10.1016/S2213-8587(24)00308-5. Online ahead of print. Lancet Diabetes Endocrinol. 2025. PMID: 39824204
15,113 results
You have reached the last available page of results. Please see the User Guide for more information.